Enhanced cytotoxicity of benzimidazole carbamate derivatives and solubilisation by encapsulation in cucurbit[n]uril

Organic and Biomolecular Chemistry

Volumn 8, Issue 14, 2010, Pages 3328-3337

  Zhao, Yunjie ^a   Pourgholami, Mohammad H ^b   Morris, David L ^b   Collins, J Grant ^a   Day, Anthony I ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; ANTI-CANCER AGENTS; AQUEOUS SOLUBILITY; BENZIMIDAZOLES; CARBAMATE DERIVATIVES; COLORECTAL CANCER CELL; CUCURBIT[N]URIL; CYTOTOXIC; H NMR SPECTROSCOPY; HUMAN PROSTATE CANCER CELLS; SOLUBILISATION; STRUCTURE-ACTIVITY;

CELL CULTURE; CELLS; CYTOTOXICITY; FUNCTIONAL GROUPS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; RESONANCE; SOLUBILITY;

ISOMERS;

ANTINEOPLASTIC AGENT; BENZIMIDAZOLE; BENZIMIDAZOLE DERIVATIVE; BRIDGED COMPOUND; CARBAMIC ACID DERIVATIVE; WATER;

ARTICLE; CELL PROLIFERATION; CELL STRAIN HT29; CHEMISTRY; DRUG EFFECT; HUMAN; SOLUBILITY; STRUCTURE ACTIVITY RELATION; SYNTHESIS; DRUG EFFECTS; HT 29 CELL LINE;

ANTINEOPLASTIC AGENTS; BENZIMIDAZOLES; BRIDGED COMPOUNDS; CARBAMATES; CELL PROLIFERATION; HT29 CELLS; HUMANS; SOLUBILITY; STRUCTURE-ACTIVITY RELATIONSHIP; WATER;

EID: 77954601548     PISSN: 14770520     EISSN: None     Source Type: Journal    
DOI: 10.1039/c003732j     Document Type: Article

References (25)

1. D. L. Morris P. W. Dykes B. Dickson S. E. Marriner J. A. Bogan F. G. O. Burrows Br. Med. J. 1983 286 103
2. K. Hanjeet R. G. Mathias Acta Trop. 1991 50 111
3. W. T. James and T. W. Leslie, Drugs used in the chemotherapy of helminthiasis. In The pharmacological basis of therapeutics by Goodman and Gilman, 9th edition. McGraw Hill, New York
4. M. H. Pourgholami L. Woon R. Almajd J. Akhter P. Bowery D. L. Morris Cancer Lett. 2001 165 43
5. M. H. Pourgholami J. Akhter L. Wang Y. Lu D. L. Morris Cancer Chemother. Pharmacol. 2005 55 425
6. M. H. Pourgholami Z. Y. Cai L. Wang S. Badar M. Links D. L. Morris Cancer Invest. 2009 27 171
7. A. Khalilzadeh K. T. Wangoo D. L. Morris M. H. Pourgholami Biochem. Pharmacol. 2007 74 407
8. M. H. Pourgholami Z. Yan Cai Y. Lu L. Wang D. L. Morris Clin. Cancer Res. 2006 12 1928
9. C. A. S. Bergstrom C. M. Wassvik K. Johansson I. Hubatsch J. Med. Chem. 2007 50 5858
10. Y. Zhao D. P. Buck D. L. Morris M. H. Pourgholami A. I. Day J. G. Collins Org. Biomol. Chem. 2008 6 4509
11. W. A. Freeman W. L. Mock N.-Y. Shih J. Am. Chem. Soc. 1981 103 7367
12. J. Kim I.-S. Jung S.-Y. Kim E. Lee J.-K. Kang S. Sakamoto K. Yamaguchi K. Kim J. Am. Chem. Soc. 2000 122 540
13. A. I. Day A. P. Arnold R. J. Blanch B. Snushall J. Org. Chem. 2001 66 8094
14. A. I. Day R. J. Blanch A. P. Arnold S. Lorenzo G. R. Lewis I. Dance Angew. Chem., Int. Ed. 2002 41 275
15. S. Liu P. Y. Zavalij L. Isaacs J. Am. Chem. Soc. 2005 127 16798
16. P. Cintas J. Inclusion Phenom. Mol. Recognit. Chem. 1994 17 205
17. N. Dong S.-F. Xue Q.-J. Zhu Z. Tao Y. Zhao L.-X. Yang Supramol. Chem. 2008 659
18. N. J. Wheate A. I. Day R. J. Blanch A. P. Arnold C. Cullinane J. G. Collins Chem. Commun. 2004 1424
19. V. J. Stella K. W. Nti-Addae Adv. Drug Delivery Rev. 2007 59 677
20. W. L. Mock N.-Y. Shih J. Org. Chem. 1986 51 4440
21. A. I. Day A. P. Arnold R. J. Blanch B. Snushell J. Org. Chem. 2001 66 8094
22. S. E. Marriner D. L. Morris B. Dickson J. A. Bogan Eur. J. Clin. Pharmacol. 1986 30 705
23. Y.-M. Jeon J. Kim D. Wang K. Kim J. Am. Chem. Soc. 1996 118 9790
24. H.-Y. Fu S.-F. Xue Q.-J. Zhu Z. Tao J.-X. Zhang A. I. Day J. Inclusion Phenom. Macrocyclic Chem. 2005 52 101
25. N. Saleh A. L. Koner W. M. Nau Angew. Chem., Int. Ed. 2008 47 5398